A Controlled Trial of Reserpine in Chronic Schizophrenia
- 1 October 1960
- journal article
- Published by Royal College of Psychiatrists in Journal of Mental Science
- Vol. 106 (445), 1408-1412
- https://doi.org/10.1192/bjp.106.445.1408
Abstract
Since the introduction of reserpine by Kline in 1954 there have been relatively few studies of its use in schizophrenia and most of these have been uncontrolled. It is characteristic of these uncontrolled trials that when the results are assessed, they are described in glowing terms, and the percentage of patients reported as showing “moderate” or “marked” improvement is high.Keywords
This publication has 9 references indexed in Scilit:
- Trial of Reserpine in Treatment of SchizophreniaBMJ, 1957
- A CONTROLLED CLINICAL STUDY OF CHLORPROMAZINE AND RESERPINE IN CHRONIC SCHIZOPHRENIAJournal of Neurology, Neurosurgery & Psychiatry, 1956
- THE EFFECTS OF RESERPINE (SERPASIL®) ON THE CHRONIC DISTURBED SCHIZOPHRENICJournal of Nervous & Mental Disease, 1956
- CLINICAL, PSYCHOLOGICAL AND MYONEURAL CHANGES IN PSYCHOTIC PATIENTS UNDER ORAL SERPASIL MEDICATIONJournal of Nervous & Mental Disease, 1955
- TREATMENT OF TWO HUNDRED DISTURBED PSYCHOTICS WITH RESERPINEJAMA, 1955
- RESERPINE (SERPASIL) IN THE MANAGEMENT OF THE MENTALLY ILLJAMA, 1955
- TREATMENT OF CHRONIC SCHIZOPHRENIC REACTIONS WITH RESERPINEAnnals of the New York Academy of Sciences, 1955
- THE USE OF RESERPINE IN SHOCK‐REVERSIBLE PATIENTS AND SHOCK‐RESISTANT PATIENTSAnnals of the New York Academy of Sciences, 1955
- THE CONTROL OF DEVIANT BEHAVIOR IN CHRONICALLY DISTURBED PSYCHOTIC PATIENTS BY THE ORAL ADMINISTRATION OF RESERPINEAnnals of the New York Academy of Sciences, 1955